Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
35313 | 99 | 26.2 | 70% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
12 | 4 | POLYMER SCIENCE//MATERIALS SCIENCE, PAPER & WOOD//CHEMISTRY, PHYSICAL | 1084170 |
41 | 3 | INTERNATIONAL JOURNAL OF PHARMACEUTICS//DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY//PHARMACOLOGY & PHARMACY | 99449 |
147 | 2 | SOLID LIPID NANOPARTICLES//POLYMERIC MICELLES//LIPOSOMES | 23275 |
35313 | 1 | MULTIVESICULAR LIPOSOMES//DOUBLE LIPOSOMES//DEPOFOAM | 99 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | MULTIVESICULAR LIPOSOMES | authKW | 3183535 | 17% | 61% | 17 |
2 | DOUBLE LIPOSOMES | authKW | 1101571 | 5% | 71% | 5 |
3 | DEPOFOAM | authKW | 705004 | 4% | 57% | 4 |
4 | GLASS FILTER METHOD | authKW | 616881 | 2% | 100% | 2 |
5 | SUSTAINED GRANULOPOIESIS | authKW | 616881 | 2% | 100% | 2 |
6 | PLURONIC NANOPARTICLES | authKW | 555191 | 3% | 60% | 3 |
7 | MULTILAYER NANOPARTICLES | authKW | 411253 | 2% | 67% | 2 |
8 | MVLS | authKW | 411253 | 2% | 67% | 2 |
9 | BIOMECH TISSUE ENGN SATE | address | 308441 | 1% | 100% | 1 |
10 | CANCER TARGETABILITY | authKW | 308441 | 1% | 100% | 1 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 945 | 57% | 0% | 56 |
2 | Materials Science, Biomaterials | 171 | 7% | 0% | 7 |
3 | Chemistry, Medicinal | 101 | 10% | 0% | 10 |
4 | Chemistry, Multidisciplinary | 68 | 19% | 0% | 19 |
5 | Oncology | 39 | 12% | 0% | 12 |
6 | Biophysics | 38 | 8% | 0% | 8 |
7 | Engineering, Petroleum | 36 | 2% | 0% | 2 |
8 | Engineering, Biomedical | 19 | 4% | 0% | 4 |
9 | Biotechnology & Applied Microbiology | 17 | 7% | 0% | 7 |
10 | Biochemistry & Molecular Biology | 10 | 13% | 0% | 13 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | BIOMECH TISSUE ENGN SATE | 308441 | 1% | 100% | 1 |
2 | OFFICINAL MATH | 308441 | 1% | 100% | 1 |
3 | PROC DATA TECHNOL | 308441 | 1% | 100% | 1 |
4 | PROT PROD DEV | 308441 | 1% | 100% | 1 |
5 | UNIT PHARMACOL CANC TREATMENT | 308441 | 1% | 100% | 1 |
6 | PROC DEV MFG | 185060 | 3% | 20% | 3 |
7 | NANOBIOMAT S | 176245 | 4% | 14% | 4 |
8 | MED PLICAT LASERS | 34269 | 1% | 11% | 1 |
9 | RCCFC | 30842 | 1% | 10% | 1 |
10 | PHARMACEUT PROJECTS | 19580 | 2% | 3% | 2 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | BIOPHARM-THE APPLIED TECHNOLOGIES OF BIOPHARMACEUTICAL DEVELOPMENT | 43555 | 5% | 3% | 5 |
2 | DRUG DELIVERY | 3800 | 4% | 0% | 4 |
3 | JOURNAL OF CONTROLLED RELEASE | 2652 | 8% | 0% | 8 |
4 | ANTIBIOTIKI I KHIMIOTERAPIYA | 2101 | 2% | 0% | 2 |
5 | CANCER CHEMOTHERAPY AND PHARMACOLOGY | 2056 | 7% | 0% | 7 |
6 | BULLETIN OF CANADIAN PETROLEUM GEOLOGY | 2022 | 2% | 0% | 2 |
7 | DISSOLUTION TECHNOLOGIES | 1503 | 1% | 0% | 1 |
8 | CANCER TREATMENT REPORTS | 557 | 2% | 0% | 2 |
9 | JOURNAL OF LIPOSOME RESEARCH | 523 | 1% | 0% | 1 |
10 | DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY | 511 | 3% | 0% | 3 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | MULTIVESICULAR LIPOSOMES | 3183535 | 17% | 61% | 17 | Search MULTIVESICULAR+LIPOSOMES | Search MULTIVESICULAR+LIPOSOMES |
2 | DOUBLE LIPOSOMES | 1101571 | 5% | 71% | 5 | Search DOUBLE+LIPOSOMES | Search DOUBLE+LIPOSOMES |
3 | DEPOFOAM | 705004 | 4% | 57% | 4 | Search DEPOFOAM | Search DEPOFOAM |
4 | GLASS FILTER METHOD | 616881 | 2% | 100% | 2 | Search GLASS+FILTER+METHOD | Search GLASS+FILTER+METHOD |
5 | SUSTAINED GRANULOPOIESIS | 616881 | 2% | 100% | 2 | Search SUSTAINED+GRANULOPOIESIS | Search SUSTAINED+GRANULOPOIESIS |
6 | PLURONIC NANOPARTICLES | 555191 | 3% | 60% | 3 | Search PLURONIC+NANOPARTICLES | Search PLURONIC+NANOPARTICLES |
7 | MULTILAYER NANOPARTICLES | 411253 | 2% | 67% | 2 | Search MULTILAYER+NANOPARTICLES | Search MULTILAYER+NANOPARTICLES |
8 | MVLS | 411253 | 2% | 67% | 2 | Search MVLS | Search MVLS |
9 | CANCER TARGETABILITY | 308441 | 1% | 100% | 1 | Search CANCER+TARGETABILITY | Search CANCER+TARGETABILITY |
10 | CHIMERIC GROWTH FACTOR | 308441 | 1% | 100% | 1 | Search CHIMERIC+GROWTH+FACTOR | Search CHIMERIC+GROWTH+FACTOR |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | ZHONG, HJ , DENG, YJ , WANG, XM , YANG, BH , (2005) MULTIVESICULAR LIPOSOME FORMULATION FOR THE SUSTAINED DELIVERY OF BREVISCAPINE.INTERNATIONAL JOURNAL OF PHARMACEUTICS. VOL. 301. ISSUE 1-2. P. 15-24 | 16 | 70% | 27 |
2 | RAJVAIDYA, M , GUPTA, Y , JAIN, A , JAIN, SK , (2007) DEVELOPMENT AND CHARACTERIZATION OF MULTIVESICULAR LIPOSOMES BEARING SERRATIOPEPTIDASE FOR SUSTAINED DELIVERY.JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY. VOL. 17. ISSUE 5. P. 315-320 | 16 | 67% | 0 |
3 | ANGST, MS , DROVER, DR , (2006) PHARMACOLOGY OF DRUGS FORMULATED WITH DEPOFOAM (TM) - A SUSTAINED RELEASE DRUG DELIVERY SYSTEM FOR PARENTERAL ADMINISTRATION USING MULTIVESICULAR LIPOSOME TECHNOLOGY.CLINICAL PHARMACOKINETICS. VOL. 45. ISSUE 12. P. 1153-1176 | 27 | 35% | 43 |
4 | ZHAO, Y , LIU, J , SUN, X , ZHANG, ZR , GONG, T , (2010) SUSTAINED RELEASE OF HYDROXYCAMPTOTHECIN AFTER SUBCUTANEOUS ADMINISTRATION USING A NOVEL PHOSPHOLIPID COMPLEX-DEPOFOAM (TM) TECHNOLOGY.DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY. VOL. 36. ISSUE 7. P. 823 -831 | 14 | 54% | 1 |
5 | SHEN, Y , JI, YX , XU, SJ , CHEN, DQ , TU, JS , (2011) MULTIVESICULAR LIPOSOME FORMULATIONS FOR THE SUSTAINED DELIVERY OF ROPIVACAINE HYDROCHLORIDE: PREPARATION, CHARACTERIZATION, AND PHARMACOKINETICS.DRUG DELIVERY. VOL. 18. ISSUE 5. P. 361 -366 | 8 | 80% | 9 |
6 | ELLENA, JF , LE, M , CAFISO, DS , SOLIS, RM , LANGSTON, M , SANKARAM, MB , (1999) DISTRIBUTION OF PHOSPHOLIPIDS AND TRIGLYCERIDES IN MULTIVESICULAR LIPID PARTICLES.DRUG DELIVERY. VOL. 6. ISSUE 2. P. 97-106 | 12 | 75% | 18 |
7 | HE, SJ , ZHU, JB , XIE, FM , (2010) PREPARATION AND CHARACTERIZATION OF TRAMADOL PEG-COATED MULTIVESICULAR LIPOSOMES FOR SUSTAINED RELEASE.PHARMAZIE. VOL. 65. ISSUE 7. P. 467-470 | 8 | 80% | 4 |
8 | SUN, LJ , WANG, T , GAO, LJ , QUAN, DQ , FENG, DH , (2013) MULTIVESICULAR LIPOSOMES FOR SUSTAINED RELEASE OF NALTREXONE HYDROCHLORIDE: DESIGN, CHARACTERIZATION AND IN VITRO/IN VIVO EVALUATION.PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY. VOL. 18. ISSUE 4. P. 828-833 | 9 | 56% | 1 |
9 | MANTRIPRAGADA, S , (2002) A LIPID BASED DEPOT (DEPOFOAM((R)) TECHNOLOGY) FOR SUSTAINED RELEASE DRUG DELIVERY.PROGRESS IN LIPID RESEARCH. VOL. 41. ISSUE 5. P. 392-406 | 6 | 86% | 58 |
10 | HOWELL, SB , (2001) CLINICAL APPLICATIONS OF A NOVEL SUSTAINED-RELEASE INJECTABLE DRUG DELIVERY SYSTEM: DEPOFOAM (TM) TECHNOLOGY.CANCER JOURNAL. VOL. 7. ISSUE 3. P. 219-227 | 17 | 29% | 45 |
Classes with closest relation at Level 1 |